Home  >  News
Disease Profile + Font Resize -

LDG India introduces advanced cancer treatments 'immunotherapy with dendritic cells'

Our Bureau, Mumbai
Friday, January 12, 2018, 17:00 Hrs  [IST]

Aiming to provide new hope for cancer patients across the country, LDG India has initiated world famous LANEX-DC immunotherapy medical facility in India in collaboration with renowned Germany-based laboratory “Dr. Gansuage”. Immunotherapy with dendritic cells is a combination therapy that helps body’s own defences fight cancer cells.

This one of the most innovative and advanced cancer treatments, immunotherapy with dendritic cells infuses is a new ray of hope for cancer patients. Countless research and treatment facilities worldwide have increasingly turned towards this dendritic cell therapy; many modern nations like USA have well accepted and approved this treatment.

India is not far behind as this treatment has already been in use for a while. And now with more advancement where the treatment will be done in one cycle will be provided by Germany based doctor “Dr. Frank Gansauge” in India.

Treatment with dendtritic cells is often used when conventional therapies have not been successful. This treatment has been recently introduced in India and many patients have been cured with encouraging results under the supervision of renowned Oncologist.

For most types of cancer, however, there exist standard treatments which have been developed over decades. It is recommended to make use of these treatments and supplement them with immune therapy, since it is known that tumour cells damaged by chemotherapy or radiation are much easier to destroy with immune cells than undamaged tumour cells.

LDG India provides the cancer treatment through only 1 dendritic cell rich dose which takes a total of one week to process. A patient can take the vaccination while taking chemotherapy, it will averse the side effects and help a patient live a routine life.

The facility provides a special type of vaccination, required to treat any type of cancer (except-blood cancer), at any stage.  A unique vaccination is made from patient’s blood and infused in the body which boost their immunity and help in curing the disease naturally.

“We are proud of the medical advancements and with Immunotherapy cancer patients are surely going to benefit as this treatment has largely proven its effectiveness worldwide.” says Tapesh Singhal, Director, LDG India who has taken the baton forward to introduce this medical facility in India and Indian Subcontinents (except China).

At present cancer is taking thousands of lives every year worldwide including India. About one hundred different types of cancer are known in humans, and all are different from one another such as the average age at which they appear, the growth rate and the tendency to metastasize. Therefore, it is rather questionable whether a single main cause for the development of cancer will ever be identified.

Scientists working on immunotherapy have basically taken a diverse route by tricking the body’s own defences into combating the rival cancer within. For centuries, this has been an aspiration of medical scientist which has become a reality. The effectiveness of a treatment with dendritic cells could be proven in the case of skin, kidney, breast, pancreatic, colon, ovarian and prostate cancer, and other cancers.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
kalyan roy Apr 16, 2018 1:23 PM
I want to know whether it is appliacble to Metastatic Breast Cancer who has been undergoing the statotory treatment regime of chemotharapy + Targetted Therapy and then Targetted Tharapy alone for the last one and what more benifit in relard to the expected period of Desase Free Survival or Progerassion Free Survival of the pateiet, whether it is approved by FDA/CDSCO (approved in India) and what would be the esmitated cost of the treatment .
suchithra c Mar 27, 2018 2:53 PM
Want to know more about immunotherapy, please do contact me or provide me a contact num.
my Ph no:8884664592
 
CPhI-WW-Banners-150X60-120618-anim-v2
pharmalytica_150x60_2018
CPhI_MEA_Banner_150x60_2018
150X60px_biowavers
IPE_2018_Banner_150X60
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
CPhI_China_150x60-2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |